Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel Battegay

Showing results (1-10 of 420) with videos related to

Pageof 42
Sort By:
Journal of the International AIDS Society|November 14, 2014
Choice of initial therapyManuel Battegay
ALTEX|January 1, 1993
[Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates]Manuel Battegay
Therapeutische Umschau. Revue Therapeutique|January 8, 2014
[When to start antiretroviral therapy]Luigia Elzi, Manuel Battegay
Current Opinion in HIV and AIDS|April 18, 2009
Clinical spectrum of the immune restoration inflammatory syndromeManuel Battegay, Henning Drechsler
Therapeutische Umschau. Revue Therapeutique|August 6, 2014
[Epidemiology of HIV]Bruno Ledergerber, Manuel Battegay
Lancet (London, England)|August 9, 2014
Does HIV antiretroviral therapy still need its backbone?Manuel Battegay, Luigia Elzi
Swiss Medical Weekly|October 20, 2009
Morbidity and mortality in HIV-infected individuals - a shift towards comorbiditiesManuel Battegay, Luigia Elzi
Enfermedades Infecciosas Y Microbiologia Clinica|June 26, 2012
Do we need national guidelines on human immunodeficiency virus treatment?Emilio Letang, Manuel Battegay
Current Problems in Dermatology|March 2, 2012
Skin problems in immunodeficient patientsPeter H Itin, Manuel Battegay
AIDS (London, England)|December 25, 2009
Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy?Manuel Battegay, Heiner C Bucher
Pageof 42

Showing results (1-10 of 420) with videos related to

Sort By:
Pageof 42
Journal of the International AIDS Society|November 14, 2014
Choice of initial therapyManuel Battegay
ALTEX|January 1, 1993
[Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 well plates]Manuel Battegay
Therapeutische Umschau. Revue Therapeutique|January 8, 2014
[When to start antiretroviral therapy]Luigia Elzi, Manuel Battegay
Current Opinion in HIV and AIDS|April 18, 2009
Clinical spectrum of the immune restoration inflammatory syndromeManuel Battegay, Henning Drechsler
Therapeutische Umschau. Revue Therapeutique|August 6, 2014
[Epidemiology of HIV]Bruno Ledergerber, Manuel Battegay
Lancet (London, England)|August 9, 2014
Does HIV antiretroviral therapy still need its backbone?Manuel Battegay, Luigia Elzi
Swiss Medical Weekly|October 20, 2009
Morbidity and mortality in HIV-infected individuals - a shift towards comorbiditiesManuel Battegay, Luigia Elzi
Enfermedades Infecciosas Y Microbiologia Clinica|June 26, 2012
Do we need national guidelines on human immunodeficiency virus treatment?Emilio Letang, Manuel Battegay
Current Problems in Dermatology|March 2, 2012
Skin problems in immunodeficient patientsPeter H Itin, Manuel Battegay
AIDS (London, England)|December 25, 2009
Antiretroviral monotherapy: should we abandon the principles of successful antiretroviral therapy?Manuel Battegay, Heiner C Bucher
Pageof 42